Retrospective Study
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastrointest Endosc. Oct 16, 2014; 6(10): 493-498
Published online Oct 16, 2014. doi: 10.4253/wjge.v6.i10.493
Table 2 Comparison between the delayed bleeding group and the uneventful group n (%)
Delayed bleeding n = 25Uneventful group n = 2990P value
Age, mean ± SD, yr58.4 ± 10.159.6 ± 10.40.646
Male15 (60.0)1756 (58.7)0.898
Laboratory before EMR
Hemoglobin, g/dL13.2 ± 1.413.66 ± 1.80.187
Platelet, × 103 count/mm360.5 ± 12.171.9 ± 1.30.81
Prothrombin time, INR0.984 ± 0.0670.989 ± 0.5280.785
Activated partial thromboplastin time, s33.8 ± 4.434.9 ± 23.20.665
Comorbidity
Hypertension5 (20.0)559 (18.7)0.800
Cardiovascular or cerebrovascular disease5 (20.0)384 (12.8)0.362
Chronic renal failure2 (8.0)21 (0.7)0.015
Liver cirrhosis1 (4.0)74 (2.5)0.131
Diabetes mellitus3 (12.0)154 (5.1)0.140
Cancer history3 (12.0)350 (11.7)1.000
Anti-coagulants and anti-platelets
Aspirin3 (12.0)250 (8.4)1.000
Clopidogrel1 (4.0)56 (1.9)0.381
Warfarin0 (0.0)43 (1.4)1.000
Size of lesion, mean ± SD, mm25.8 ± 11.611.0 ± 6.6< 0.001
Locations
Right side colon18 (32.0)1288 (43.1)0.314
Morphologic classification
Pedunculated11 (44.0)539 (18.0)0.003
Piecemeal resection6 (24.0)124 (4.1)0.001
Pathologic complete resection25 (100.0)2954 (79.9)1.000
Horizontal margin involvement0 (0.0)31 (1.0)1.000
Vertical margin involvement0 (0.0)10 (0.3)1.000
Serious immediate bleeding23 (12.0)75 (2.5)0.025
Prophylactic hemostatic clipping4 (16.0)341 (11.4)0.319
Histology
Adenoma23 (92.0)2337 (78.2)0.140
Carcinoma1 (4.0 )88 (18.4)0.529
Hyperplastic polyp1 (4.0)412 (13.8)0.240
Others0 (0.0)90 (3.0)1.000